Agreement - December 20, 2013
AstraZeneca buys Bristol-Myers Squibb share of global diabetes alliance assets
According to the agreement AstraZeneca will acquire the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance for an initial consideration of $2.7 billion on completion and up to $1.4 billion in regulatory, launch and sales-related payments. Furthermore, AstraZeneca has agreed to pay various sales-related royalty payments up until 2025. In addition, AstraZeneca states […]
Acquisition - December 20, 2013
Bayer buys Algeta
Bayer plans to acquire Norwegian pharmaceutical company Algeta. The Bayer Group plans to further strengthen its oncology portfolio with the acquisition of Norwegian pharmaceutical company Algeta ASA, Oslo, according to a press release. Bayer has already collaborated with Algeta to develop and commercialize the cancer drug Xofigo. The planned acquisition would give Bayer full control […]
Drug Development Pharma - December 18, 2013
BerGenBio presents promising data for CML treatment
Norwegian oncology biopharmaceutical company BerGenBio has presented results from preclinical studies on the agent BGB324 which suggest that the cancer therapy may be effective as new treatment for patients with drug resistant Chronic Myeloid Leukemia (CML). The data was presented at the Annual Meeting of the American Society of Hematology (ASH), which took place on December 7-10, […]
In a new job - December 17, 2013
MAX IV gets new chairman
Professor Hans Hertz has been elected as chairman of the board at MAX IV, succeeding Lars Börjesson. Hans Hertz is a professor of biomedical physics at the Royal Institute of Technology (KTH) and is also a member of the Royal Swedish Academy of Sciences and the Royal Swedish Academy of Engineering Sciences, IVA. According to a […]
Uncategorized - December 17, 2013
Stockholm County Council to finance Swetox
The research center Swetox is getting SEK 30 million in funding from the Stockholm County Council. The money is to be divided across three years. “We are very happy that the Stockholm County Council also wants to contribute to the funding. This means that we will be able to make the most of the unique condition […]
Agreement - December 16, 2013
New agreement on collaboration rules
Public healthcare and the pharma, medtech and laboratory technical industries get new collaboration rules. Swedish Medtech has entered an agreement with the Swedish Association of Local Authorities and Regions, the trade association for the research-based pharmaceutical industry (LIF) and Swedish Labtech about the collaboration rules. The new agreement describes the parties view on product and […]
